+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunohematology Market by Product Type, Application, End-User - Global Forecast to 2030- Product Image
Immunohematology Market by Product Type, Application, End-User - Global Forecast to 2030- Product Image
Sale

Immunohematology Market by Product Type, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454916
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immunohematology market is evolving, propelled by fast-paced technological integration, regulatory shifts, and rising clinical demands. Opportunities and challenges in laboratory automation, advanced diagnostics, and supply chain resilience are driving strategic choices for industry leaders.

Market Snapshot: Immunohematology Market Overview

The Immunohematology Market grew from USD 2.22 billion in 2024 to USD 2.40 billion in 2025. It is expected to continue growing at a CAGR of 8.27%, reaching USD 3.59 billion by 2030. Shaped by continued demand for safe transfusion practices and next-generation laboratory solutions, the sector promises substantial value creation for healthcare stakeholders navigating complex regulatory and operational environments.

Scope & Segmentation

This analysis examines the most influential factors, product categories, and player strategies within the global immunohematology sector. Market scope includes:

  • Product Types:
    • Analyzers & systems
    • Fully-automated solutions
    • Semi-automated systems
    • Reagents & kits
  • Application Areas:
    • Antibody screening
    • Blood transfusion
    • Disease diagnosis
    • Pregnancy testing protocols
  • End-Users:
    • Blood banks
    • Diagnostic laboratories
    • Hospitals
    • Research institutes
  • Regions Covered:
    • Americas: United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Key Companies:
    • Abbott Laboratories, AliveDx Suisse SA, Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biomed Global, Cardinal Health, Inc., CSL Limited, DIAGAST, F. Hoffmann-La Roche Ltd., Grifols, S.A., Immucor, Inc., Merck KGaA, QuidelOrtho Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., VWR International, LLC.

Key Takeaways: Strategic Insights for Immunohematology

  • Automation in immunohematology workflows is increasing rapidly, replacing manual approaches and supporting both high-volume and flexible laboratory settings.
  • Adoption of digital data platforms and cloud-enabled quality management systems is enhancing operational efficiency and compliance across distributed laboratories.
  • Emerging point-of-care technologies, enabled by advances in microfluidics, are expanding access to antibody screening and blood typing in decentralized and emergency settings.
  • Manufacturers are leveraging local production and contract partnerships to respond to shifts in sourcing patterns and maintain supply continuity amid regulatory changes.
  • Competition is shifting from product-only offerings to value-added services such as extended maintenance, predictive diagnostics, and bundled reagent contracts.

Tariff Impact: U.S. Regulatory Developments and Market Response

New U.S. tariffs implemented in 2025 have increased input costs for reagents and instrument components, affecting procurement and supply chain strategy throughout the immunohematology sector. To counteract these challenges, manufacturers have accelerated domestic production, and laboratories are diversifying supplier relationships. Bundled service agreements now play a key role in stabilizing costs and mitigating risk, prompting broader supply chain optimization initiatives and reinforcing the importance of dual-sourcing frameworks.

Methodology & Data Sources

This report’s findings derive from rigorous multi-phase research, combining secondary analysis of journals, filings, and industry databases, with primary interviews from executives, laboratory directors, and procurement specialists. Quantitative validation and expert panel reviews have ensured analytical integrity and unbiased insights throughout.

Why This Report Matters

  • Empowers senior decision-makers with strategic clarity on evolving immunohematology market dynamics, including technology adoption and supply chain resilience.
  • Enables risk mitigation through detailed segmentation, regional market analysis, and benchmarking of competitive strategies.
  • Supports informed investment in automation, digital platforms, and sourcing initiatives aligned to specific operational and regulatory needs.

Conclusion

The immunohematology market is aligning around automation, digital transformation, and adaptive supply strategies. Companies taking a multifaceted, forward-looking approach will be best positioned to address clinical needs and optimize value in a changing landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immunohematology Market, by Product Type
8.1. Introduction
8.2. Analyzers & Systems
8.2.1. Fully-Automated
8.2.2. Semi-Automated
8.3. Reagents & Kits
9. Immunohematology Market, by Application
9.1. Introduction
9.2. Antibody Screening
9.3. Blood Transfusion
9.4. Disease Diagnosis
9.5. Pregnancy
10. Immunohematology Market, by End-User
10.1. Introduction
10.2. Blood Banks
10.3. Diagnostic Laboratories
10.4. Hospitals
10.5. Research Institutes
11. Americas Immunohematology Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Immunohematology Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Immunohematology Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Abbott Laboratories
14.3.2. AliveDx Suisse SA
14.3.3. Beckman Coulter, Inc.
14.3.4. Becton Dickinson and Company
14.3.5. Bio-Rad Laboratories, Inc.
14.3.6. Biomed Global
14.3.7. Cardinal Health, Inc.
14.3.8. CSL Limited
14.3.9. DIAGAST
14.3.10. F. Hoffmann-La Roche Ltd.
14.3.11. Grifols, S.A.
14.3.12. Immucor, Inc.
14.3.13. Merck KGaA
14.3.14. QuidelOrtho Corporation
14.3.15. Siemens Healthineers AG
14.3.16. Sysmex Corporation
14.3.17. Thermo Fisher Scientific, Inc.
14.3.18. VWR International, LLC.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. IMMUNOHEMATOLOGY MARKET MULTI-CURRENCY
FIGURE 2. IMMUNOHEMATOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. IMMUNOHEMATOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. IMMUNOHEMATOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. IMMUNOHEMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. IMMUNOHEMATOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY FULLY-AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PREGNANCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 34. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 38. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 55. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 59. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 63. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 67. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 71. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 75. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 79. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 91. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 95. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 99. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 103. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 107. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 115. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 119. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 127. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 131. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 142. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 144. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 148. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 152. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 160. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 168. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 176. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 184. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
TABLE 188. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. IMMUNOHEMATOLOGY MARKET SHARE, BY KEY PLAYER, 2024
TABLE 191. IMMUNOHEMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Immunohematology market report include:
  • Abbott Laboratories
  • AliveDx Suisse SA
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomed Global
  • Cardinal Health, Inc.
  • CSL Limited
  • DIAGAST
  • F. Hoffmann-La Roche Ltd.
  • Grifols, S.A.
  • Immucor, Inc.
  • Merck KGaA
  • QuidelOrtho Corporation
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • VWR International, LLC.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.4 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.59 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Immunohematology Analyzers and Reagents - Global Strategic Business Report - Product Image

Immunohematology Analyzers and Reagents - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Immunohematology Market Report by Product, Application, End-User, and Region 2024-2032 - Product Image

Immunohematology Market Report by Product, Application, End-User, and Region 2024-2032

  • Report
  • 135 Pages
  • Global
From
Immunohematology Market Report 2025 - Product Image

Immunohematology Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Immunohematology Market Opportunities and Strategies to 2034 - Product Image

Immunohematology Market Opportunities and Strategies to 2034

  • Report
  • 282 Pages
  • Global
From
2024 Global Transfusion Medicine Market: Immunohematology and NAT Analyzers and Reagents - Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities - Product Image

2024 Global Transfusion Medicine Market: Immunohematology and NAT Analyzers and Reagents - Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

  • Report
  • Global
From

About the Immunohematology Market

Immunohematology is a branch of medicine that focuses on the study of blood and its components, particularly the antigens and antibodies that are involved in the immune system. It is a key component of transfusion medicine, which is the practice of transfusing blood and its components to patients in need. Immunohematology is also used in the diagnosis and treatment of various blood disorders, such as hemophilia and sickle cell anemia. Immunohematology is a major part of the pharmaceutical industry, as it is used to develop and manufacture drugs and treatments for blood-related diseases. It is also used to develop and manufacture blood products, such as red blood cells, platelets, and plasma, for transfusion. Additionally, immunohematology is used to develop and manufacture diagnostic tests for blood-related diseases. Some companies in the immunohematology market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.